One of the primary benefits of CPOE in cancer care is the reduction of medication errors. The system offers built-in clinical decision support, which alerts physicians to potential drug interactions, incorrect dosages, and patient allergies. This proactivity greatly reduces the chance of adverse drug events, which are particularly harmful to cancer patients who are often immunocompromised.
